NASH FibroSure Plus & R Plus Test: Labcorp 550960, Quest, CPT Code, Blood Test & Results Guide

Content:

• What is NASH FibroSure Plus & R Plus Test?
• Labcorp 550960
• Quest
• CPT Code
• Blood Test
• Results Guide

What is NASH FibroSure Plus & R Plus Test?

The NASH FibroSure Plus and R Plus tests are advanced non-invasive blood tests designed to help assess liver health, particularly in patients who may have nonalcoholic steatohepatitis (NASH) or other forms of liver disease. These tests use a combination of biochemical markers, along with an algorithm, to evaluate the likelihood and severity of liver fibrosis, necroinflammatory activity, and steatosis. They are useful alternatives to liver biopsy, offering a quicker, safer, and more comfortable diagnostic option for patients.

NASH FibroSure Plus focuses on patients with suspected NASH, whereas the R Plus variant includes additional parameters for broader liver health evaluation. Physicians may order these tests for patients with abnormal liver function tests, metabolic syndrome, obesity, diabetes, or unexplained fatigue and abdominal discomfort. The results can guide treatment plans, lifestyle modifications, and monitoring over time.

Labcorp 550960

Labcorp offers the NASH FibroSure Plus test under the test number **550960**. It requires a simple blood draw and typically has a turnaround time of a few days. Labcorp processes the sample in specialized laboratories, applying proprietary algorithms to provide results that quantify liver fibrosis, steatosis, and necroinflammatory activity. The test does not require fasting, although your healthcare provider may recommend certain preparation steps.

Ordering through Labcorp ensures standardized sample handling and result interpretation. Healthcare professionals can access the detailed report online, which includes numerical scores, reference ranges, and an easy-to-read interpretation. The Labcorp test number is important for proper ordering and insurance billing, ensuring patients receive the correct diagnostic evaluation.

Quest

Quest Diagnostics also offers similar liver fibrosis and steatosis assessment tests, often under different branding. While Quest may not use the exact name "NASH FibroSure Plus," their offerings function similarly, using biochemical markers and algorithms to estimate liver damage. Physicians can select the appropriate test from the Quest catalog, depending on the patient’s history and clinical findings.

Patients may choose Quest over Labcorp based on location, insurance coverage, or physician preference. Regardless of the provider, the principle remains the same: these tests help reduce the need for invasive liver biopsies and support long-term liver health monitoring.

CPT Code

The CPT code for NASH FibroSure Plus may vary depending on the lab and the specific components ordered. Common codes include those for liver fibrosis scoring, quantitative biochemical analysis, and algorithm-based interpretation. Healthcare providers use CPT codes for billing, insurance claims, and proper test identification.

When ordering through Labcorp or Quest, the CPT code is automatically linked to the test in their system, which helps streamline reimbursement. Patients should check with their insurance provider to confirm coverage, as some payers may require prior authorization for advanced diagnostic panels.

Blood Test

The NASH FibroSure Plus and R Plus tests are blood-based, meaning they require no special imaging or surgical procedures. A venous blood sample is collected and analyzed for specific biochemical markers such as alpha-2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, and GGT. The results are combined with patient age, gender, height, and weight to generate an overall score.

Because it’s minimally invasive, this test is ideal for patients who need repeated monitoring. It is often performed alongside other liver function tests, lipid profiles, and metabolic panels for a complete health picture.

Results Guide

The results from NASH FibroSure Plus & R Plus tests are provided as numerical scores with corresponding fibrosis stages and activity grades. These stages range from F0 (no fibrosis) to F4 (cirrhosis). The report typically includes a graphical display, making it easier for both doctors and patients to understand.

Interpretation should always be done by a qualified healthcare provider, as results can be influenced by other conditions such as inflammation, acute illness, or certain medications. Based on results, the provider may recommend lifestyle changes, medical treatment, or further diagnostic evaluation.